MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $147 | 0.0% | 6,355 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $147 | -0.7% | 6,355 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $148 | +11.3% | 6,355 | -9.0% | 0.00% | 0.0% |
Q4 2022 | $133 | -99.9% | 6,983 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $133,000 | +4.7% | 6,983 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $127,000 | +296.9% | 6,983 | +505.6% | 0.00% | – |
Q4 2021 | $32,000 | -13.5% | 1,153 | 0.0% | 0.00% | – |
Q3 2021 | $37,000 | -96.1% | 1,153 | -96.3% | 0.00% | -100.0% |
Q2 2021 | $960,000 | +24.7% | 31,404 | +24.1% | 0.00% | 0.0% |
Q1 2021 | $770,000 | -72.0% | 25,312 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $2,753,000 | +620.7% | 25,312 | -13.6% | 0.00% | 0.0% |
Q3 2020 | $382,000 | -10.3% | 29,304 | -21.9% | 0.00% | 0.0% |
Q2 2020 | $426,000 | -31.5% | 37,498 | -13.8% | 0.00% | -80.0% |
Q1 2020 | $622,000 | -29.0% | 43,484 | +35.2% | 0.01% | -16.7% |
Q4 2019 | $876,000 | -4.9% | 32,164 | 0.0% | 0.01% | -14.3% |
Q3 2019 | $921,000 | +3.0% | 32,164 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $894,000 | -16.3% | 32,164 | 0.0% | 0.01% | -22.2% |
Q1 2019 | $1,068,000 | +145.5% | 32,164 | +115.1% | 0.01% | +80.0% |
Q4 2018 | $435,000 | -77.9% | 14,955 | -65.0% | 0.01% | -66.7% |
Q3 2018 | $1,965,000 | +370.1% | 42,719 | +281.9% | 0.02% | +275.0% |
Q2 2018 | $418,000 | -4.1% | 11,187 | -24.3% | 0.00% | 0.0% |
Q1 2018 | $436,000 | +76.5% | 14,770 | +105.3% | 0.00% | +100.0% |
Q4 2017 | $247,000 | +30.7% | 7,193 | +37.5% | 0.00% | 0.0% |
Q3 2017 | $189,000 | +40.0% | 5,231 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $135,000 | +35.0% | 5,231 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $100,000 | -95.3% | 5,231 | -95.9% | 0.00% | -95.2% |
Q4 2016 | $2,109,000 | -12.7% | 126,534 | +7.8% | 0.02% | -27.6% |
Q3 2016 | $2,417,000 | -6.6% | 117,431 | +38.8% | 0.03% | -21.6% |
Q2 2016 | $2,589,000 | -8.7% | 84,595 | +11.7% | 0.04% | -21.3% |
Q1 2016 | $2,835,000 | -23.9% | 75,754 | -12.2% | 0.05% | -31.9% |
Q4 2015 | $3,725,000 | +46.6% | 86,312 | +27.3% | 0.07% | +35.3% |
Q3 2015 | $2,541,000 | -37.0% | 67,788 | -42.9% | 0.05% | -1.9% |
Q2 2015 | $4,033,000 | -11.4% | 118,662 | -7.7% | 0.05% | -10.3% |
Q1 2015 | $4,550,000 | +38.8% | 128,544 | +33.5% | 0.06% | +48.7% |
Q4 2014 | $3,279,000 | +243.0% | 96,266 | +288.2% | 0.04% | +18.2% |
Q3 2014 | $956,000 | -69.9% | 24,796 | -69.6% | 0.03% | -8.3% |
Q2 2014 | $3,173,000 | +183.3% | 81,534 | +148.9% | 0.04% | +100.0% |
Q1 2014 | $1,120,000 | +63.0% | 32,759 | 0.0% | 0.02% | +80.0% |
Q4 2013 | $687,000 | +1.5% | 32,759 | +13.9% | 0.01% | -9.1% |
Q3 2013 | $677,000 | -15.9% | 28,773 | -4.0% | 0.01% | -26.7% |
Q2 2013 | $805,000 | – | 29,983 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |